Inpatient obstetric management of COVID-19

Semin Perinatol. 2020 Nov;44(7):151280. doi: 10.1016/j.semperi.2020.151280. Epub 2020 Jul 21.

Abstract

Objective: To describe inpatient management strategies and considerations for pregnant patients with severe acute respiratory syndrome coronavirus 2 infection.

Findings: The novel coronavirus has posed challenges to both obstetric patients and the staff caring for them, due to its variable presentation and current limited knowledge about the disease. Inpatient antepartum, intrapartum and postpartum management can be informed by risk stratification, severity of disease, and gestational age. Careful planning and anticipation of emergent situations can prevent unnecessary exposures to patients and clinical staff.

Conclusion: As new data arises, management recommendations will evolve, thus practitioners must maintain a low threshold for adaptation of their clinical practice during obstetric care for patients with severe acute respiratory syndrome coronavirus 2 infection.

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Anti-Bacterial Agents / therapeutic use
  • Anticoagulants / therapeutic use
  • Antiviral Agents / therapeutic use
  • COVID-19 / diagnosis
  • COVID-19 / therapy*
  • COVID-19 Drug Treatment
  • COVID-19 Nucleic Acid Testing
  • COVID-19 Serotherapy
  • Cesarean Section
  • Chorioamnionitis / diagnosis
  • Delivery Rooms
  • Delivery, Obstetric*
  • Diagnosis, Differential
  • Disease Management
  • Endometritis / diagnosis
  • Female
  • Fetal Monitoring*
  • Fetal Organ Maturity
  • Gestational Age
  • HELLP Syndrome / diagnosis
  • Hospitalization*
  • Humans
  • Immunization, Passive
  • Influenza, Human / diagnosis
  • Intensive Care Units
  • Labor, Induced
  • Obstetric Labor, Premature / drug therapy
  • Patient Discharge
  • Patient Isolators
  • Personal Protective Equipment
  • Postnatal Care
  • Practice Guidelines as Topic
  • Pre-Eclampsia / diagnosis
  • Pregnancy
  • Pregnancy Complications, Infectious / therapy*
  • Pyelonephritis / diagnosis
  • Rooming-in Care
  • SARS-CoV-2
  • Severity of Illness Index
  • Thrombosis / prevention & control
  • Time Factors
  • Tocolytic Agents / therapeutic use

Substances

  • Adrenal Cortex Hormones
  • Anti-Bacterial Agents
  • Anticoagulants
  • Antiviral Agents
  • Tocolytic Agents